News from AIDS 2012

The 19th International AIDS Conference (AIDS 2012) took place in Washington, USA, 22nd-27th July 2012.

As the official online partner for scientific reporting, NAM published original news reporting and free email bulletins.

aidsmap news from AIDS 2012

Taking isoniazid preventive therapy for one year reduces the risk of TB in people taking antiretroviral therapy

Twelve months of isoniazid (INH) preventive therapy (IPT) significantly reduced the incidence of all TB diagnoses among HIV-positive people who were taking concurrent antiretroviral therapy (ART) according to

Published
27 July 2012
By
Theo Smart
First generic HIV drugs could save US at least $920 million a year

Even using very conservative estimates of efficacy, using two generic HIV drugs plus one branded one in the most popular first-line regimen instead of using all three

Published
27 July 2012
By
Gus Cairns
Latest data on HIV cure research

Investigators presented some of the latest HIV cure-related research at a press conference and oral session on viral reservoirs at the 19th International AIDS Conference (AIDS 2012)

Published
27 July 2012
By
Liz Highleyman
Determine LAM urine antigen TB test is highly cost-effective for use in hospitalised people living with HIV

The lateral-flow urine LAM test for tuberculosis – a simple inexpensive strip test for tuberculosis – is a feasible point-of-care test in hospitalised South African adults living

Published
27 July 2012
By
Theo Smart
Dolutegravir matches raltegravir for people starting treatment

The novel integrase inhibitor dolutegravir worked as well as raltegravir (Isentress) at 48 weeks for treatment-naive people in the Phase III SPRING-2 study, according to a late-breaker

Published
27 July 2012
By
Liz Highleyman
HIV treatment for children: how programmes are improving diagnosis and retention

“It is unacceptable that children at this point in time are not receiving treatment,” René Ekpini of UNICEF told a satellite session supported by UNICEF, IAS-ILF and MSH

Published
27 July 2012
By
Carole Leach-Lemens
Does injectable hormonal contraception increase the risk of HIV infection?

The 19th International AIDS Conference (AIDS 2012) heard further contradictory evidence this week on whether hormonal contraceptives, especially injectable ones, raise the risk to women of acquiring

Published
27 July 2012
By
Gus Cairns
HIV infection does not compromise multidrug-resistant TB treatment outcomes in Botswana

HIV infection did not have an impact on the time it took for people with multidrug-resistant tuberculosis (MDR-TB) to reach culture conversion, according to a study from

Published
27 July 2012
By
Lesley Odendal
Mobile technologies playing a growing role in HIV care and treatment support

A number of studies presented at the 19th International AIDS Conference (AIDS 2012) in Washington DC highlighted potentially important roles for mobile phone technology in the delivery of

Published
27 July 2012
By
Kelly Safreed-Harmon
In the real world HIV has changed; in the courtroom it is still the 1980s

In the midwestern American state of Michigan, prosecutors and judges still consider HIV infection to be a death sentence and are dismissive of scientifically grounded arguments about

Published
26 July 2012
By
Roger Pebody

Sign up today

Sign up for our regular email bulletins:

Find out more and sign up to the full range of aidsmap email bulletins >

AIDS 2012 tweets

Click here for more >

More coverage of the conference

Two other official partners of the conference are providing coverage and analysis online.

Clinical Care Options (CCO) provide audio highlights, capsule summaries and downloadable slidesets, while the Kaiser Family Foundation provide webcasting from conference sessions.

NAM is partnering with UNICEF to deliver the AIDS 2012 bulletins, which have also been made possible thanks to support from Bristol-Myers Squibb and Vestergaard Frandsen. NAM’s wider conference news reporting services have been supported by Abbott, Boehringer Ingelheim, Janssen, Roche and ViiV Healthcare.